T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Agilent Technologies, Inc. (NYSE:A) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 8,143,863 shares of the Healthcare company, valued at approximately $1.1B as of the filing date.
Agilent Technologies, Inc.'s stock currently trades at $124.60 with a market capitalization of $40.5B.